SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-028374
Filing Date
2019-12-02
Accepted
2019-12-02 20:57:29
Documents
1
Period of Report
2019-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3635
  Complete submission text file 0000899243-19-028374.txt   5264
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address 324 S. HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address
Hasara Garrison J. (Reporting) CIK: 0001510349 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13467 | Film No.: 191264417